EP3849599 - PNEUMOCOCCAL FUSION PROTEIN VACCINES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 18.06.2021 Database last updated on 22.08.2024 | |
Former | The international publication has been made Status updated on 21.03.2020 | Most recent event Tooltip | 27.09.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states The Children's Medical Center Corporation 55 Shattuck Street Boston, Massachusetts 02115 / US | [2021/29] | Inventor(s) | 01 /
MALLEY, Richard 15 Bayview Avenue Beverly, Massachusetts 01915 / US | 02 /
LU, Yingjie 188 Corey St. West Roxbury, Massachusetts 02132 / US | 03 /
ZHANG, Fan 188 Corey St. West Roxbury, Massachusetts 02132 / US | [2021/29] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
Former [2021/29] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19860907.5 | 12.09.2019 | [2021/29] | WO2019US50800 | Priority number, date | US201862730199P | 12.09.2018 Original published format: US 201862730199 P | [2021/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020056127 | Date: | 19.03.2020 | Language: | EN | [2020/12] | Type: | A1 Application with search report | No.: | EP3849599 | Date: | 21.07.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.03.2020 takes the place of the publication of the European patent application. | [2021/29] | Search report(s) | International search report - published on: | US | 19.03.2020 | (Supplementary) European search report - dispatched on: | EP | 30.05.2022 | Classification | IPC: | A61K39/09, A61K39/116 | [2021/29] | CPC: |
C12N15/62 (EP,IL);
C07K14/3156 (EP,IL,KR,US);
C07K14/47 (IL,US);
A61K39/092 (EP,IL,KR);
A61P31/04 (KR);
A61K2039/6031 (EP,IL,KR);
A61K2039/627 (EP,IL,KR);
A61K2039/70 (EP,IL,KR);
C07K2319/00 (IL,US);
C07K2319/20 (EP,IL,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/29] | Title | German: | PNEUMOKOKKEN-FUSIONSPROTEINIMPFSTOFFE | [2021/29] | English: | PNEUMOCOCCAL FUSION PROTEIN VACCINES | [2021/29] | French: | VACCINS À PROTÉINES DE FUSION PNEUMOCOCCIQUES | [2021/29] | Entry into regional phase | 31.03.2021 | National basic fee paid | 31.03.2021 | Search fee paid | 31.03.2021 | Designation fee(s) paid | 31.03.2021 | Examination fee paid | Examination procedure | 31.03.2021 | Examination requested [2021/29] | 30.01.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 31.03.2021 | Renewal fee patent year 03 | 27.09.2022 | Renewal fee patent year 04 | 27.09.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2014124228 (CHILDRENS MEDICAL CENTER [US]); | [E]EP3849587 (AFFINIVAX INC [US]); | International search | [A]WO2014018904 (GENOCEA BIOSCIENCES INC [US], et al); | [XY]US2015374811 (MALLEY RICHARD [US], et al); | [Y]US2016090404 (MALLEY RICHARD [US], et al) |